Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SafiledCriticalSanofi Sa
Priority to NZ594215ApriorityCriticalpatent/NZ594215A/en
Priority claimed from PCT/IN2009/000071external-prioritypatent/WO2010084500A1/en
Publication of NZ594215ApublicationCriticalpatent/NZ594215A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
594215 Disclosed is a pharmaceutical composition in the form of a solid dosage form containing a combination of granulated ketoprofen (non-steroidal anti-inflammatory drug NSAID) and granulated thiocolchicoside (colchicoside derivative), the active ingredients being present in the free state or in the form of a salt , wherein the ketoprofen and thicolchicoside are granulated separately prior to combination in the tablet. Also disclosed is the method of preparing the composition and the use of the composition in the manufacture of a medicament for ameliorating and/or treating musculoskeletal and joint disorders, peri-articular disorders and painful muscle spasm.
NZ594215A2009-01-222009-01-22New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
NZ594215A
(en)
Procedure for the manufacture of a pharmaceutical composition in the form of long-acting pirfenidone-containing tablets and their application in the regression of chronic renal failure, human breast capsular contracture and hepatic fibrosis
Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
Use of 10 - [(3r) -1-azabicyclo] oct-3-ylmethyl] -10-h-phenothiazine, or one of its pharmaceutically acceptable salts for the preparation of a useful medicine to prevent or treat obstructive bronchopneumopathy.